SLC12A5 and thyroid gland carcinoma: Moreover, it was shown to inhibit aggressive thyroid cancer behaviors by suppressing the lncRNA FOXD3‐AS1 by elevating miR‐296‐5p and inactivating the TGF‐β1/Smad signaling pathway, which aligns with the increased expression of FOXD3 observed in our study [35] SLC12A5, on the other hand, plays a critical role in tumor cell proliferation, metastasis, invasion, and apoptosis regulation.